Perioperative assessment of terlipressin infusion during living donor liver transplantation

Journal of International Medical Research

Volumn 40, Issue 1, 2012, Pages 225-236

  Hong, S H ^a   Lee, J M ^a   Choi, J H ^a   Chung, H S ^a   Park, J H ^a   Park, Chul Soo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Inotrope; Living donor liver transplantation; Pulmonary vascular resistance index; Renal function; Systemic vascular resistance index; Terlipressin; Vasopressor

Indexed keywords

ADRENALIN; DOBUTAMINE; NORADRENALIN; TERLIPRESSIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT REJECTION; HUMAN; HYPOTENSION; INFECTION; INTENSIVE CARE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LENGTH OF STAY; LIVER TRANSPLANTATION; LIVING DONOR; LUNG VASCULAR RESISTANCE; MALE; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE; THROMBOSIS; URINE VOLUME;

EID: 84863264455     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000123     Document Type: Article

References (28)

1. Hennenberg M, Trebicka J, Sauerbruch T, et al: Mechanisms of extrahepatic vasodilation in portal hypertension. Gut 2008; 57: 1300-1314.
2. Skagen CL, Said A: Vasoconstrictor use in liver transplantation: is there evidence for rational use? Minerva Gastroenterol Dietol 2010; 56: 279-296.
3. Schroeder RA, Collins BH, Tuttle-Newhall E, et al: Intraoperative fluid management during orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2004; 18: 438-441.
4. Dudkiewicz M, Proctor KG: Tissue oxygenation during management of cerebral perfusion pressure with phenylephrine or vasopressin. Crit Care Med 2008; 36: 2641-2650.
5. Huang YT, Lin HC, Chang YY, et al: Hemodynamic effects of synephrine treatment in portal hypertensive rats. Jpn J Pharmacol 2001; 85: 183-188.
6. Bellomo R, Kellum JA, Wisniewski SR, et al: Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med 1999; 159: 1186-1192.
7. Zhang LP, Li M, Yang L: Effects of different vasopressors on hemodynamics in patients undergoing orthotopic liver transplantation. Chin Med J (Engl) 2005; 118: 1952-1958.
8. Wagener G, Gubitosa G, Renz J, et al: Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation. Liver Transpl 2008; 14: 1664-1670.
9. Ponnudurai RN, Koneru B, Akhtar SA, et al: Vasopressor administration during liver transplant surgery and its effect on endotracheal reintubation rate in the postoperative period: a prospective, randomized, double-blind, placebo-controlled trial. Clin Ther 2005; 27: 192-198.
10. Moreau R, Asselah T, Condat B, et al: Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study. Gut 2002; 50: 90-94.
11. Mukhtar A, Salah M, Aboulfetouh F, et al: The use of terlipressin during living donor liver transplantation: effects on systemic and splanchnic hemodynamics and renal function. Crit Care Med 2011; 39: 1329-1334.
12. Morelli A, Ertmer C, Rehberg S, et al: Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care 2009; 13: R130.
13. Rodríguez-Núñez A, Oulego-Erroz I, Gil-Antón J, et al: Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock. Ann Pharmacother 2010; 44: 1545-1553.
14. Pugh RN, Murray-Lyon IM, Dawson JL, et al: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649.
15. Kamath PS, Wiesner RH, Malinchoc M, et al: A model to predict survival in patients with endstage liver disease. Hepatology 2001; 33: 464-470.
16. Mehrabi A, Golling M, Kashfi A, et al: Negative impact of systemic catecholamine administration on hepatic blood perfusion after porcine liver transplantation. Liver Transpl 2005; 11: 174-187.
17. Feltracco P, Barbieri S, Galligioni H, et al: Intensive care management of liver transplanted patients. World J Hepatol 2011; 3: 61-71.
18. Morelli A, Ertmer C, Lange M, et al: Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better? Intensive CareMed 2007; 33: 1669-1670.
19. Umgelter A, Reindl W, Schmid RM, et al: Continuous terlipressin infusion in patients with persistent septic shock and cirrhosis of the liver. Intensive Care Med 2008; 34: 390-391.
20. Mandell MS, Katz JJ, Wachs M, et al: Circulatory pathophysiology and options in hemodynamic management during adult liver transplantation. Liver Transpl Surg 1997; 3: 379-387.
21. Møller S, Bendtsen F, Henriksen JH: Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 1995; 109: 1917-1925.
22. Garutti Martinez I, Olmedilla L, Perez-Peña JM, et al: Response to clamping of the inferior vena cava as a factor for predicting postreperfusion syndrome during liver transplantation. Anesth Analg 1997; 84: 254-259.
23. Krag A, Bendtsen F, Mortensen C, et al: Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis. Eur J Gastroenterol Hepatol 2010; 22: 1085-1092.
24. Sagi SV, Mittal S, Kasturi KS, et al: Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2010; 25: 880-885.
25. Hadengue A, Gadano A, Moreau R, et al: Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol 1998; 29: 565-570.
26. Holte K, Sharrock NE, Kehlet H: Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth 2002; 89: 622-632.
27. Triantos CK, Nikolopoulou V, Burroughs AK: Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis. Aliment Pharmacol Ther 2008; 28: 943-952.
28. Yagi S, Iida T, Taniguchi K, et al: Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation. Liver Transpl 2005; 11: 68-75.